HEALTHCARERecent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
Irvine-based Masimo Corp. today reported third-quarter results that exceeded Wall Street expectations.
Irvine-based ChromaDex Corp. said today it signed a joint development deal with Cincinnati-based conglomerate Proctor & Gamble Co.
HEALTHCARE: $211M deal trims market capitalization by 30% in day
Endologix Inc.’s bid to grow market share through a newly struck deal to acquire a competitor appears to have set investors in the Irvine-based medical device maker on edge.
HEALTHCARE: Europe rollout, Salus trial, mitral valves in plan
Medical device maker Direct Flow Medical Inc., which maintains a Lake Forest manufacturing hub, is pursuing a three-pronged plan for progress under new leadership.
Santa Ana-based MP Biomedicals LLC was sold to Valiant Co. in China for about $134 million.
Local Units Part of 23% Revenue Hike on Dental
Units with an Orange County presence helped drive improved financial performance for Danaher Corp.’s third quarter, according to company executives.
Shares in Allergan PLC rose about 9% in morning trading after the drug maker and potential partner Pfizer Inc. confirmed the two companies were discussing a merger.
Shares of Irvine-based medical device maker Endologix Inc. plummeted today on news of a third-quarter loss.
Irvine-based Edwards Lifesciences Corp. reported financial results today that exceeded expectations and sent its shares up in after-hours trading.
Santa Ana-based MP Biomedicals LLC has been sold to Valiant Co., Ltd., in China for about $134 million.
Allergan PLC finalized its purchase of Aliso Viejo-based AqueSys Inc. for $300 million plus milestone payments.
Irvine-based cardiovascular device maker Edwards Lifesciences Corp. said today that it signed a deal with San Diego-based CareFusion, a BD company, to enable a pair of their respective devices to work together.
Irvine-based Quality Systems Inc. sold the hospital software division of its NextGen Healthcare subsidiary to Reston, Va.-based QuadraMed Affinity Corp. A purchase price was not disclosed.
Trading of shares in Allergan PLC, whose Botox and eye drug hubs are in Irvine, was briefly halted today and are down in midday trading on news involving rival Valeant Pharmaceuticals International Inc.
Former Allergan executive David Crean will be managing director of the life sciences investment banking group of San Diego investment bank Objective Capital Partners, the bank said.